Oasmia Pharmaceutical AB (publ) Interim report for the period May 1 – October 31, 2019

NEXT STORY
Lotus to distribute Orion’s Stalevo® and Comtan® drugs in parts of Asia
PREV STORY
World Markets for Pediatric Medicines, Forecast to 2024
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sonoma Pharmaceuticals Announces Newly Published Results from Study of Hypochlorous Acid in Management of Hypertrophic and Keloid Scars

author_avatar
NASDAQ Market News

UroGen Pharma Appoints Former Kite Pharma Chief Operating Officer Cynthia M. Butitta to its Board of Directors

RA’ANANA, Israel and NEW YORK, Nov. 02, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...

author_avatar
NASDAQ Market News

Patient Recruitment & Retention Services Market, Forecast to 2030 – Evolving Requirements Related to Patient Enrolment Have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource

author_avatar
NASDAQ Market News